Fendrix

Fendrix is a vaccine designed to prevent hepatitis B infection. It contains aluminium phosphate and hepatitis B surface antigen, adjuvanted by AS04C and adsorbed on aluminium. This vaccine is administered intramuscularly and is manufactured by GlaxoSmithKline Biologicals S.A.

Fendrix is primarily used for the prevention of hepatitis B infection. It is administered to individuals who are at risk of contracting the virus, such as those with chronic liver disease or those who are in close contact with infected individuals. The vaccine works by stimulating the body's immune response to the hepatitis B virus, helping to protect against future infection.

Common effects of Fendrix may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever, fatigue, or headache. These effects are typically mild and short-lived. Serious side effects are rare but should be reported to a healthcare professional.

Fendrix should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Individuals with weakened immune systems may have a reduced response to the vaccine.

Fendrix may interact with other medications or vaccines. It is important to discuss all current medications with a healthcare provider before receiving the vaccine. Alcohol and certain supplements may also affect the body's response to the vaccine.